Inogen's Scribner to leave
By HME News Staff
Updated Wed August 29, 2018
GOLETA, Calif. - Matt Scribner, Inogen's executive vice president of operations, will leave the company, effective Jan. 2, 2019. Bart Sanford, most recently senior vice president of operations at Cepheid, a molecular diagnostics company, will step into the role on Sept. 17, 2018, to ensure an orderly transition, according to a press release. “Matt has been a part of the company's success and I want to thank him for his many contributions to Inogen over the years and wish him the best in his future endeavors,” said CEO Scott Wilkinson. “We are looking forward to Bart's contributions as we continue to drive portable oxygen concentrators to become the standard of care for ambulatory oxygen patients worldwide in this large and growing market.”
Comments